196 related articles for article (PubMed ID: 28588253)
1. Nucleotide excision repair is a potential therapeutic target in multiple myeloma.
Szalat R; Samur MK; Fulciniti M; Lopez M; Nanjappa P; Cleynen A; Wen K; Kumar S; Perini T; Calkins AS; Reznichenko E; Chauhan D; Tai YT; Shammas MA; Anderson KC; Fermand JP; Arnulf B; Avet-Loiseau H; Lazaro JB; Munshi NC
Leukemia; 2018 Jan; 32(1):111-119. PubMed ID: 28588253
[TBL] [Abstract][Full Text] [Related]
2. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3.
Vermeulen W; Scott RJ; Rodgers S; Müller HJ; Cole J; Arlett CF; Kleijer WJ; Bootsma D; Hoeijmakers JH; Weeda G
Am J Hum Genet; 1994 Feb; 54(2):191-200. PubMed ID: 8304337
[TBL] [Abstract][Full Text] [Related]
3. The xeroderma pigmentosum group B protein ERCC3 produced in the baculovirus system exhibits DNA helicase activity.
Ma L; Siemssen ED; Noteborn HM; van der Eb AJ
Nucleic Acids Res; 1994 Oct; 22(20):4095-102. PubMed ID: 7937133
[TBL] [Abstract][Full Text] [Related]
4. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.
Calmels N; Greff G; Obringer C; Kempf N; Gasnier C; Tarabeux J; Miguet M; Baujat G; Bessis D; Bretones P; Cavau A; Digeon B; Doco-Fenzy M; Doray B; Feillet F; Gardeazabal J; Gener B; Julia S; Llano-Rivas I; Mazur A; Michot C; Renaldo-Robin F; Rossi M; Sabouraud P; Keren B; Depienne C; Muller J; Mandel JL; Laugel V
Orphanet J Rare Dis; 2016 Mar; 11():26. PubMed ID: 27004399
[TBL] [Abstract][Full Text] [Related]
5. Newly identified CHO ERCC3/XPB mutations and phenotype characterization.
Rybanská I; Gursky J; Fasková M; Salazar EP; Kimlícková-Polakovicová E; Kleibl K; Thompson LH; Pirsel M
Mutagenesis; 2010 Mar; 25(2):179-85. PubMed ID: 19942596
[TBL] [Abstract][Full Text] [Related]
6. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.
Coin F; Bergmann E; Tremeau-Bravard A; Egly JM
EMBO J; 1999 Mar; 18(5):1357-66. PubMed ID: 10064601
[TBL] [Abstract][Full Text] [Related]
7. Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH).
van Vuuren AJ; Vermeulen W; Ma L; Weeda G; Appeldoorn E; Jaspers NG; van der Eb AJ; Bootsma D; Hoeijmakers JH; Humbert S
EMBO J; 1994 Apr; 13(7):1645-53. PubMed ID: 8157004
[TBL] [Abstract][Full Text] [Related]
8. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
[TBL] [Abstract][Full Text] [Related]
9. XPB: An unconventional SF2 DNA helicase.
Fan L; DuPrez KT
Prog Biophys Mol Biol; 2015 Mar; 117(2-3):174-181. PubMed ID: 25641424
[TBL] [Abstract][Full Text] [Related]
10. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
11. The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
Rocca CJ; Poindessous V; Soares DG; Ouadrani KE; Sarasin A; Guérin E; de Gramont A; Henriques JA; Escargueil AE; Larsen AK
Biochem Pharmacol; 2010 Aug; 80(3):335-43. PubMed ID: 20399198
[TBL] [Abstract][Full Text] [Related]
12. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
Damia G; Imperatori L; Stefanini M; D'Incalci M
Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity.
Coin F; Auriol J; Tapias A; Clivio P; Vermeulen W; Egly JM
EMBO J; 2004 Dec; 23(24):4835-46. PubMed ID: 15549133
[TBL] [Abstract][Full Text] [Related]
17. The long unwinding road: XPB and XPD helicases in damaged DNA opening.
Oksenych V; Coin F
Cell Cycle; 2010 Jan; 9(1):90-6. PubMed ID: 20016270
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ERCC3 mutations in the Chinese hamster ovary 27-1, UV24 and MMC-2 cell lines.
Hall H; Gurský J; Nicodemou A; Rybanská I; Kimlícková E; Pirsel M
Mutat Res; 2006 Jan; 593(1-2):177-86. PubMed ID: 16143348
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair.
Coin F; Oksenych V; Egly JM
Mol Cell; 2007 Apr; 26(2):245-56. PubMed ID: 17466626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
